{"id":"https://openalex.org/W2590192834","doi":"https://doi.org/10.1200/jco.2008.26.15_suppl.6518","title":"Factors associated with participant adherence in the NSABP Study of Tamoxifen and Raloxifene (STAR)","display_name":"Factors associated with participant adherence in the NSABP Study of Tamoxifen and Raloxifene (STAR)","publication_year":2008,"publication_date":"2008-05-20","ids":{"openalex":"https://openalex.org/W2590192834","doi":"https://doi.org/10.1200/jco.2008.26.15_suppl.6518","mag":"2590192834"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2008.26.15_suppl.6518","doi":"https://doi.org/10.1200/jco.2008.26.15_suppl.6518","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2008.26.15_suppl.6518","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020711450","display_name":"Walter M. Cronin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W. M. Cronin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006334177","display_name":"Reena S. Cecchini","orcid":"https://orcid.org/0000-0002-9075-9357","observed_orcids":["https://orcid.org/0000-0002-9075-9357"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. S. Cecchini","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073338995","display_name":"Donald Lawrence Wickerham","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. L. Wickerham","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108678675","display_name":"V. G. Vogel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V. G. Vogel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109391408","display_name":"J. P. Costantino","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. P. Costantino","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5055013606","display_name":"Norman Wolmark","orcid":"https://orcid.org/0000-0001-7156-1110","observed_orcids":["https://orcid.org/0000-0001-7156-1110"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N. Wolmark","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"26","issue":"15_suppl","first_page":"6518","last_page":"6518"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.9678000211715698,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.9678000211715698,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10582","display_name":"Ethics in Clinical Research","score":0.004100000020116568,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.003599999938160181,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/star-trial","display_name":"STAR trial","score":0.8339999914169312},{"id":"https://openalex.org/keywords/raloxifene","display_name":"raloxifene","score":0.878000020980835},{"id":"https://openalex.org/keywords/tamoxifen","display_name":"tamoxifen","score":1.0},{"id":"https://openalex.org/keywords/breast-cancer-prevention","display_name":"breast cancer prevention","score":0.8410000205039978},{"id":"https://openalex.org/keywords/participant-adherence","display_name":"participant adherence","score":0.6000000238418579},{"id":"https://openalex.org/keywords/medication-persistence","display_name":"treatment persistence","score":0.8159999847412109},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.7839999794960022},{"id":"https://openalex.org/keywords/pre-existing-conditions","display_name":"pre-existing conditions","score":0.8640000224113464},{"id":"https://openalex.org/keywords/recruitment-sources","display_name":"recruitment sources","score":0.7950000166893005},{"id":"https://openalex.org/keywords/patient-selection","display_name":"patient selection","score":0.5540000200271606},{"id":"https://openalex.org/keywords/clinical-trial-compliance","display_name":"clinical trial compliance","score":0.722000002861023}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8865175843238831},{"id":"https://openalex.org/C81603835","wikidata":"https://www.wikidata.org/wiki/Q3457430","display_name":"Pill","level":2,"score":0.692868709564209},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6095763444900513},{"id":"https://openalex.org/C2777176818","wikidata":"https://www.wikidata.org/wiki/Q412178","display_name":"Tamoxifen","level":4,"score":0.5582592487335205},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5109883546829224},{"id":"https://openalex.org/C27415008","wikidata":"https://www.wikidata.org/wiki/Q7256382","display_name":"Psychological intervention","level":2,"score":0.4744126498699188},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.45756796002388},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.4558464586734772},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4388580024242401},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37551969289779663},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2644164562225342},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.21001073718070984},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.07350635528564453},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2008.26.15_suppl.6518","doi":"https://doi.org/10.1200/jco.2008.26.15_suppl.6518","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2008.26.15_suppl.6518","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2343239534","https://openalex.org/W1996484483","https://openalex.org/W2177428963","https://openalex.org/W2096565966","https://openalex.org/W2593873767","https://openalex.org/W2600896198","https://openalex.org/W1996337195","https://openalex.org/W2760119341","https://openalex.org/W2326292858","https://openalex.org/W2591189079"],"abstract_inverted_index":{"6518":[0],"Background:":[1],"Results":[2],"of":[3,131,140,151,162,171,179,206,243,264,275],"the":[4,32,53,77,121,152,176,180,183,190,251,270],"STAR":[5,38,185,191,254],"trial,":[6],"which":[7],"enrolled":[8],"19,747":[9],"participants":[10,134,285],"between":[11],"1999\u20132004,":[12],"showed":[13],"that":[14,119,216,225],"raloxifene":[15],"was":[16,200],"as":[17,19,96],"effective":[18],"tamoxifen":[20],"in":[21,25,189,221,231],"preventing":[22],"breast":[23,207],"cancer":[24],"women":[26],"at":[27],"increased":[28],"risk":[29,205],"for":[30,117,154,250,272,284],"developing":[31],"disease.":[33],"We":[34],"have":[35],"now":[36],"analyzed":[37],"data":[39],"on":[40,52,101,105],"adherence":[41],"(taking":[42],"2":[43],"pills":[44],"per":[45],"day)":[46],"and":[47,71,88,111,144,182,253,278,281,312,317,322],"persistence":[48,199],"(willingness":[49],"to":[50,58,64,67,123,269],"remain":[51],"protocol":[54],"regimen).":[55],"Methods:":[56],"Prior":[57],"trial":[59,78,192],"initiation,":[60],"sites":[61],"were":[62,74,90,94,115,136,164,219,256],"required":[63,142],"submit":[65],"plans":[66],"maintain":[68],"adequate":[69],"adherence,":[70],"compliance-related":[72],"factors":[73,118,163,197,239,267],"evaluated":[75],"during":[76],"via":[79],"site":[80,236],"performance":[81],"evaluations.":[82],"Participant":[83],"pre-entry":[84],"characteristics,":[85],"pill":[86],"counts,":[87],"symptoms":[89],"collected":[91],"prospectively.":[92],"Participants":[93],"categorized":[95],"persistent":[97,137],"or":[98,107,224,295,298],"non-persistent":[99],"based":[100],"whether":[102],"they":[103],"remained":[104],"therapy":[106],"withdrew.":[108],"Odds":[109],"ratios":[110],"95%":[112],"confidence":[113],"intervals":[114],"calculated":[116],"had":[120],"potential":[122,276],"affect":[124],"participant":[125,181],"adherence.":[126],"Results:":[127],"With":[128],"47":[129],"months":[130],"follow-up":[132],"data,":[133],"who":[135,147,286],"took":[138,158],"92%":[139],"their":[141,222],"pills,":[143],"even":[145],"those":[146,196],"eventually":[148],"dropped":[149],"out":[150],"study":[153,217],"non-protocol":[155],"reasons":[156],"(non-persistent)":[157],"81%.":[159],"A":[160],"number":[161],"associated":[165,257],"with":[166,258],"non-":[167],"persistence,":[168],"including":[169,240],"history":[170,242],"depression,":[172,244],"pre-existing":[173,245],"medical":[174,246],"conditions,":[175,247],"recruitment":[177,248],"source":[178,249],"responsible":[184],"site.":[186],"Conclusions:":[187],"Persistence":[188],"exceeded":[193],"expectations.":[194],"For":[195],"where":[198],"not":[201],"related":[202],"(5-year":[203],"predicted":[204],"cancer,":[208],"less":[209],"extensive":[210],"family":[211],"history,":[212],"etc.),":[213],"we":[214],"surmise":[215],"staff":[218,237],"successful":[220],"efforts":[223],"patient":[226],"selection":[227],"played":[228],"a":[229,241],"role":[230],"limiting":[232],"non-adherence.":[233],"However,":[234],"despite":[235],"interventions,":[238],"participant,":[252],"site,":[255],"higher":[259],"non-persistence":[260],"rates.":[261],"The":[262],"strength":[263],"these":[265],"predictive":[266],"points":[268],"need":[271],"careful":[273],"evaluation":[274],"participants,":[277],"continued":[279],"surveillance":[280],"compliance-promoting":[282],"interventions":[283],"are":[287],"recruited":[288],"into":[289],"clinical":[290],"trials.":[291],"Author":[292],"Disclosure":[293],"Employment":[294],"Leadership":[296],"Consultant":[297],"Advisory":[299],"Role":[300],"Stock":[301],"Ownership":[302],"Honoraria":[303],"Research":[304],"Expert":[305],"Testimony":[306],"Other":[307],"Remuneration":[308],"AstraZeneca,":[309,314,319],"Eli":[310,315,320],"Lilly":[311,316,321],"Company":[313,318,323]},"counts_by_year":[{"year":2014,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2017-03-03T00:00:00"}